Abstract
Objective: There isn't a widely accepted reference method to measure the cardiovascular disease (CVD) risk in human immunodeficiency virus (HIV)-infected patients. In our study, we aimed to investigate the presence of a parameter that would provide insight into CVD risk in HIV-positive individuals and can be conveniently used in their follow-up. Methods: This retrospective observational […]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
